Literature DB >> 21531207

Pharmacological inhibition of HDAC6 attenuates endothelial barrier dysfunction induced by thrombin.

Shigeki Saito1, Joseph A Lasky, Weichao Guo, Hong Nguyen, Antonello Mai, Svitlana Danchuk, Deborah E Sullivan, Bin Shan.   

Abstract

BACKGROUND: Endothelial barrier dysfunction (EBD) involves microtubule disassembly and enhanced cell contractility. Histone deacetylase 6 (HDAC6) deacetylates α-tubulin, and thereby destabilizes microtubules. This study investigates a role for HDAC6 in EBD.
METHODS: EBD was induced with thrombin±HDAC6 inhibitors (tubacin and MC1575), and assessed by transendothelial electrical resistance (TEER). Markers for microtubule disassembly (α-tubulin and acetylated α-tubulin) and contraction (phosphorylated myosin light chain 2, P-MLC2) were measured using immunoblots and immunofluorescence. RESULTS AND
CONCLUSION: Thrombin induced a ∼50% decrease in TEER that was abrogated by the HDAC6 inhibitors. Moreover, inhibition of HDAC6 diminished edema in the lung injured by lipopolysaccharide. Lastly, inhibition of HDAC6 attenuated thrombin-induced microtubule disassembly and P-MLC2. Our results suggest that HDAC6 can be targeted to limit EBD.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21531207      PMCID: PMC3100403          DOI: 10.1016/j.bbrc.2011.04.075

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

1.  HDAC6 is a microtubule-associated deacetylase.

Authors:  Charlotte Hubbert; Amaris Guardiola; Rong Shao; Yoshiharu Kawaguchi; Akihiro Ito; Andrew Nixon; Minoru Yoshida; Xiao-Fan Wang; Tso-Pang Yao
Journal:  Nature       Date:  2002-05-23       Impact factor: 49.962

2.  Microtubule disassembly induces cytoskeletal remodeling and lung vascular barrier dysfunction: role of Rho-dependent mechanisms.

Authors:  Anna A Birukova; Ksenya Smurova; Konstantin G Birukov; Peter Usatyuk; Feng Liu; Kozo Kaibuchi; Anila Ricks-Cord; Viswanathan Natarajan; Irina Alieva; Joe G N Garcia; Alexander D Verin
Journal:  J Cell Physiol       Date:  2004-10       Impact factor: 6.384

3.  Histone deacetylase inhibitors attenuate acute lung injury during cecal ligation and puncture-induced polymicrobial sepsis.

Authors:  Li Zhang; Shengwei Jin; Changdong Wang; Rong Jiang; Jingyuan Wan
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

4.  In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation.

Authors:  Akihisa Matsuyama; Tadahiro Shimazu; Yuko Sumida; Akiko Saito; Yasuhiro Yoshimatsu; Daphné Seigneurin-Berny; Hiroyuki Osada; Yasuhiko Komatsu; Norikazu Nishino; Saadi Khochbin; Sueharu Horinouchi; Minoru Yoshida
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

5.  Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation.

Authors:  Stephen J Haggarty; Kathryn M Koeller; Jason C Wong; Christina M Grozinger; Stuart L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-03       Impact factor: 11.205

6.  Fas/FasL-dependent apoptosis of alveolar cells after lipopolysaccharide-induced lung injury in mice.

Authors:  Y Kitamura; S Hashimoto; N Mizuta; A Kobayashi; K Kooguchi; I Fujiwara; H Nakajima
Journal:  Am J Respir Crit Care Med       Date:  2001-03       Impact factor: 21.405

7.  The role of the microtubules in tumor necrosis factor-alpha-induced endothelial cell permeability.

Authors:  Irina Petrache; Anna Birukova; Sarah I Ramirez; Joe G N Garcia; Alexander D Verin
Journal:  Am J Respir Cell Mol Biol       Date:  2003-05       Impact factor: 6.914

8.  Deactylase inhibitors disrupt cellular complexes containing protein phosphatases and deacetylases.

Authors:  Matthew H Brush; Amaris Guardiola; John H Connor; Tso-Pang Yao; Shirish Shenolikar
Journal:  J Biol Chem       Date:  2003-12-10       Impact factor: 5.157

9.  Role of Rho GTPases in thrombin-induced lung vascular endothelial cells barrier dysfunction.

Authors:  Anna A Birukova; Ksenya Smurova; Konstantin G Birukov; Kozo Kaibuchi; Joe G N Garcia; Alexander D Verin
Journal:  Microvasc Res       Date:  2004-01       Impact factor: 3.514

10.  Discovery of (aryloxopropenyl)pyrrolyl hydroxyamides as selective inhibitors of class IIa histone deacetylase homologue HD1-A.

Authors:  Antonello Mai; Silvio Massa; Riccardo Pezzi; Dante Rotili; Peter Loidl; Gerald Brosch
Journal:  J Med Chem       Date:  2003-11-06       Impact factor: 7.446

View more
  11 in total

1.  Taxol alleviates 2-methoxyestradiol-induced endothelial permeability.

Authors:  Boris A Gorshkov; Marina A Zemskova; Alexander D Verin; Natalia V Bogatcheva
Journal:  Vascul Pharmacol       Date:  2011-10-30       Impact factor: 5.773

2.  Staphylococcus aureus-induced endothelial permeability and inflammation are mediated by microtubule destabilization.

Authors:  Pratap Karki; Yunbo Ke; Yufeng Tian; Tomomi Ohmura; Albert Sitikov; Nicolene Sarich; Christopher P Montgomery; Anna A Birukova
Journal:  J Biol Chem       Date:  2019-01-08       Impact factor: 5.157

3.  Histone deacetylase inhibitor treatment attenuates coagulation imbalance in a lethal murine model of sepsis.

Authors:  Ting Zhao; Yongqing Li; Baoling Liu; Erxi Wu; Martin Sillesen; George C Velmahos; Ihab Halaweish; Hasan B Alam
Journal:  Surgery       Date:  2014-06-21       Impact factor: 3.982

Review 4.  Effects of cigarette smoke on pulmonary endothelial cells.

Authors:  Qing Lu; Eric Gottlieb; Sharon Rounds
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-01-04       Impact factor: 5.464

5.  Elevated expression of long intergenic non-coding RNA HOTAIR in a basal-like variant of MCF-7 breast cancer cells.

Authors:  Yan Zhuang; Hong T Nguyen; Matthew E Burow; Ying Zhuo; Samir S El-Dahr; Xiao Yao; Subing Cao; Erik K Flemington; Kenneth P Nephew; Fang Fang; Bridgette Collins-Burow; Lyndsay V Rhodes; Qiang Yu; Janarthanan Jayawickramarajah; Bin Shan
Journal:  Mol Carcinog       Date:  2014-10-18       Impact factor: 4.784

6.  Histone deacetylase inhibitors prevent pulmonary endothelial hyperpermeability and acute lung injury by regulating heat shock protein 90 function.

Authors:  Atul D Joshi; Nektarios Barabutis; Charalampos Birmpas; Christiana Dimitropoulou; Gagan Thangjam; Mary Cherian-Shaw; John Dennison; John D Catravas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-10-23       Impact factor: 5.464

7.  Cigarette Smoke Disrupted Lung Endothelial Barrier Integrity and Increased Susceptibility to Acute Lung Injury via Histone Deacetylase 6.

Authors:  Diana Borgas; Eboni Chambers; Julie Newton; Junsuk Ko; Stephanie Rivera; Sharon Rounds; Qing Lu
Journal:  Am J Respir Cell Mol Biol       Date:  2016-05       Impact factor: 6.914

Review 8.  Molecular Mechanisms of Vascular Damage During Lung Injury.

Authors:  Ramon Bossardi Ramos; Alejandro Pablo Adam
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Comparative analysis of novel and conventional Hsp90 inhibitors on HIF activity and angiogenic potential in clear cell renal cell carcinoma: implications for clinical evaluation.

Authors:  Jessica E S Bohonowych; Shuping Peng; Udhayakumar Gopal; Michael W Hance; Shane B Wing; Kelley M Argraves; Karen Lundgren; Jennifer S Isaacs
Journal:  BMC Cancer       Date:  2011-12-15       Impact factor: 4.430

10.  Suppression of FGFR3- and MYC-dependent oncogenesis by tubacin: association with HDAC6-dependent and independent activities.

Authors:  Sara Ota; Zi-Qiang Zhou; Peter J Hurlin
Journal:  Oncotarget       Date:  2017-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.